The Incidence of First Hickman Catheter-Related Infection and Predictors of Catheter Removal in Cancer Patients
- 1 August 1995
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 16 (8) , 451-458
- https://doi.org/10.2307/30141082
Abstract
Objective: To describe the incidence and types of first Hickman catheter-related infection (HCRI) in cancer patients and to identify indicators for catheter removal. Design: Retrospective cohort study. Setting: A regional, tertiary, referral cancer center and its supportive care university teaching hospital. Patients and Methods: A retrospective review was conducted of 316 consecutive adult oncology patients who underwent Hickman catheter placement from 1986 to 1990 at a regional oncology center. HCRI was determined on the basis of clinical information incriminating the Hickman catheter as the source of infection. Patient characteristics and data about HCRIs (exit site cellulitis, tunnel infection with concomitant exit site cellulitis, bloodstream infection, and exit site cellulitis with bloodstream infection) were abstracted from patient medical records. Subsequently, univariate and multivariate analyses for the risk of HCRI and catheter removal were completed. Results: The incidence of first HCRI was 5.98 infections per 1,000 catheter days. Overall, 156 (49%) of 316 patients developed their first HCRI prior to catheter removal. The median time to HCRI was 90 days. Male gender (P = .0004) and hematologic malignancy (P = .0001) emerged as significant risk factors for HCRI in the univariate analysis. A Cox model verified that male gender (P = .02) and hematologic malignancy (P = .004) were associated with an enhanced risk of HCRI. There were 35 exit site infections (23%), three infections of the tunnel and the exit site (2%), 80 bloodstream infections (51%), and another 38 bloodstream infections with concomitant exit site infections (24%). The incidence of bloodstream infection was 3.05 per 1,000 catheter days. Gram-positive pathogens outnumbered gram-negatives and fungi, with Staphylococcus epidermidis being most common. Fifty (32%) of 156 HCRIs resulted in catheter removal. Predictors of Hickman catheter removal in the univariate analysis were bloodstream infection (P = .046) and pathogen type (P =.006). Multiple regression analysis suggested that having a gram-negative (P = .014) or fungal (P = .057) pathogen was the most important factor for catheter removal. Conclusions: These data suggest that first HCRIs occur more commonly in male patients with hematologic malignancies than in patients with solid tumors. The removal of Hickman catheters in oncology patients probably is predicated on the causative pathogen, but further investigations are necessary to delineate this issue.Keywords
This publication has 24 references indexed in Scilit:
- A Prospective, Randomized Evaluation of the Effect of Silver Impregnated Subcutaneous Cuffs for Preventing Tunneled Chronic Venous Access Catheter Infections in Cancer PatientsAnnals of Surgery, 1993
- Infectious Complications of Indwelling Vascular CathetersClinical Infectious Diseases, 1992
- Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risksJAMA, 1992
- A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignanciesJournal of Antimicrobial Chemotherapy, 1991
- Catheter-Related Right-Sided Endocarditis in Bone Marrow Transplant RecipientsClinical Infectious Diseases, 1990
- Bacillus infections in patients with cancerArchives of internal medicine (1960), 1988
- Primary Cutaneous Aspergillosis Associated with Hickman Intravenous CathetersNew England Journal of Medicine, 1987
- COMPLICATIONS ASSOCIATED WITH INDWELLING VENOUS HICKMAN CATHETERS IN PATIENTS WITH HEMATOLOGICAL DISORDERSAustralian and New Zealand Journal of Medicine, 1986
- Perspective on the management of catheterrelated infections in cancer patientsThe Pediatric Infectious Disease Journal, 1986
- Hickman‐broviac catheter use in cancer patientsJournal of Surgical Oncology, 1984